Hereditary Colon Cancer

This is a type of colon cancer that runs in families. It's called hereditary because you inherit the tendency to get it from your parents. It's different from the type of colon cancer that causes hundreds of polyps. Instead, it usually causes one or a few growths (adenomas) that can turn into cancer later in life, often in your 40s or 50s. It's linked to specific changes in genes that fix DNA mistakes.

Condition

What people with Hereditary Colon Cancer report

Every report comes from a Lived member, sent anonymously.

Have you tried Aspirin for Hereditary Colon Cancer?

NameHow it went

About Hereditary Colon Cancer

What It Is

Hereditary nonpolyposis colorectal cancer, now usually called Lynch syndrome, is an inherited condition that raises a person's lifetime risk of colorectal cancer and several other cancers. It is not cancer itself. It is a built-in vulnerability, carried from birth, that makes cancer more likely and tends to bring it on earlier in life, often in a person's 40s or 50s rather than later. Besides the colon and rectum, the cancers most linked to Lynch syndrome are cancer of the lining of the uterus (endometrial cancer) and of the ovaries in women, along with cancers of the stomach, small intestine, urinary tract, bile ducts, brain and skin. The word nonpolyposis separates it from familial adenomatous polyposis, a different inherited condition in which hundreds of polyps carpet the colon. People with Lynch syndrome develop polyps at a younger age, but not in greater numbers. Lynch syndrome is common for a genetic condition: in the United States, roughly 1 in 279 people carry a gene change that causes it, and most of them do not know. It accounts for about 1 in 30 colorectal cancers. Finding it matters because the extra risk can be managed well once it is known.

Causes & Risk Factors

Lynch syndrome is caused by a change in one of five genes: MLH1, MSH2, MSH6, PMS2 or EPCAM. The first four are mismatch repair genes, which proofread DNA and fix the small copying errors that happen whenever a cell divides. When one copy of these genes does not work, errors can build up in a cell over time, which is how cancer can develop earlier than usual. The EPCAM change works indirectly, by switching off the neighboring MSH2 gene. The condition is passed down in an autosomal dominant pattern: one altered copy is enough, and each child of a person with Lynch syndrome has a 50% chance of inheriting it, regardless of sex. Inheriting it raises risk but does not guarantee cancer, and many carriers never develop one. How high the risk is depends on which gene is involved. Estimates of lifetime colorectal cancer risk are roughly 35 to 55 percent for MLH1 and MSH2 carriers, about 10 to 20 percent for MSH6 and around 10 percent for PMS2. For women, lifetime risk of endometrial cancer is also substantial, with estimates ranging from about 16 to over 50 percent depending on the gene. Smoking, obesity and heavier alcohol use appear to raise colorectal cancer risk further in people with Lynch syndrome, while regular physical activity appears to lower it.

How It's Diagnosed

Lynch syndrome is confirmed by a genetic test, done on a blood or saliva sample, that finds a disease-causing change in one of the five genes. People usually reach that test by one of two routes. The first starts with a cancer. Guidelines recommend that every colorectal and endometrial cancer be checked for mismatch repair deficiency. A common method is immunohistochemistry, a lab stain showing whether the four repair proteins are present in the tumor; another, microsatellite instability (MSI) testing, looks for the pattern of DNA errors these tumors leave behind. An abnormal tumor result is a flag, not a diagnosis, because many such tumors arise from a change that happened only in the tumor. Follow-up tests on the tumor help sort this out before genetic testing of the person. The second route is family history: several relatives with colorectal, endometrial or related cancers, especially at young ages, or a relative already known to have Lynch syndrome. Older family-history checklists miss many carriers, so a genetic counselor or clinician usually weighs the whole picture. Once a family's specific gene change is known, relatives can be tested for that exact change. Those who test positive can start early screening, and those who test negative generally do not need the intensive program.

Treatment Options

There is no way to correct the inherited gene change, so care focuses on finding growths early, lowering cancer risk and treating any cancer in a way that accounts for Lynch syndrome. The core of care is regular colonoscopy, an exam of the whole colon with a camera that lets the doctor find and remove polyps before they become cancer. Surveillance of this kind has been shown to reduce both colorectal cancer and deaths from it. US guidelines generally advise starting at age 20 to 25 for MLH1, MSH2 and EPCAM carriers and repeating every 1 to 2 years, and starting at 30 to 35 for MSH6 and PMS2 carriers, repeating every 1 to 3 years, or earlier if a relative had colorectal cancer very young. European guidelines start somewhat later and allow longer gaps. Good bowel preparation and a careful exam matter, because polyps in Lynch syndrome are more often flat and easier to miss. Daily aspirin can lower colorectal cancer risk. In a large trial of people with Lynch syndrome, those who took aspirin for at least two years developed fewer colorectal cancers over the following years. The best dose is still being studied, and aspirin raises the chance of stomach and intestinal bleeding, so whether to take it and at what dose is a decision to make with a clinician. For women, the uterus and ovaries carry much of the added risk. Removing the uterus, ovaries and fallopian tubes is an effective way to prevent endometrial and ovarian cancer and is generally offered to MLH1, MSH2 and MSH6 carriers from about age 35 to 40, once they have finished having children. The evidence for this surgery is weaker for PMS2 carriers. Removing the ovaries before natural menopause brings on menopause at once, so estrogen-only hormone therapy is usually advised until around age 51. Until surgery, regular review of symptoms, and for some women a sampling of the uterine lining, can help, though screening tests have not been shown to improve survival. Checks for other cancers, such as a yearly urine test, are tailored to the gene and family history. If colorectal cancer does develop, surgery is the main treatment. For MLH1 and MSH2 carriers, surgeons often recommend removing more of the colon than usual, because the remaining colon has a high chance of developing a new cancer later. The trade-off is more frequent, looser bowel movements. Tumors in Lynch syndrome are usually mismatch repair deficient, which tends to make them respond well to immunotherapy. Pembrolizumab (Keytruda), an immune checkpoint inhibitor that helps the immune system recognize cancer cells, is approved for advanced colorectal cancers of this type.

What to Expect

Living with Lynch syndrome usually means a lifelong schedule of checkups rather than a life defined by illness. Many carriers never develop cancer, and those who keep up with surveillance most often have problems found as removable polyps or at an early, treatable stage. Colonoscopy every year or few years becomes routine, including the bowel preparation the day before. The diagnosis tends to shape some larger decisions. Women often plan the timing of risk-reducing surgery around their wishes for children, and contraception and fertility are worth discussing with a specialist. Some couples look into options such as testing during pregnancy or before embryo implantation to avoid passing the gene on. Anyone who has already had a colorectal cancer remains at risk of a new one and continues surveillance. Lynch syndrome is also a family matter. A diagnosis in one person can lead parents, siblings and children to be tested, and those conversations can be difficult. Genetic counselors can help explain results and plan how to share them. Support from others who carry the same gene change can make the long-term routine feel more manageable.

When to Seek Help

Ask about genetic counseling if a relative has Lynch syndrome, if several family members have had colorectal, endometrial or related cancers, or if anyone in the family had these cancers before age 50. If you have had colorectal or endometrial cancer and do not know whether the tumor was tested for mismatch repair deficiency, ask your care team. If you have Lynch syndrome, contact your care team promptly about new symptoms rather than waiting for the next scheduled check. This includes blood in the stool, a change in bowel habits lasting more than a few days, unexplained weight loss, persistent abdominal pain or bloating, repeated urinary symptoms, and, for women, bleeding between periods or any bleeding after menopause.

Questions to Ask Your Doctor

  1. 1.Which gene is involved in my family, and what does that mean for my own cancer risks?
  2. 2.When should my colonoscopies start, how often should I have them, and what other screening makes sense for me?
  3. 3.Would daily aspirin be worthwhile for me, and at what dose given my bleeding risk?
  4. 4.How should I plan the timing of risk-reducing gynecologic surgery around my plans for children?
  5. 5.Which of my relatives should be tested, and how can I help them get genetic counseling?

Last reviewed • Oct 2026

Educational content, not medical advice.